Inhibition of histone deacetylase activity by butyrate

Journal of Nutrition

Volumn 133, Issue 7 SUPPL., 2003, Pages

  Davie, James R ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Gene expression; Histone acetylation; Histone deacetylase; p21Waf1 Cip1; Sodium butyrate; Sp1; Sp3

Indexed keywords

BUTYRIC ACID; HISTONE DEACETYLASE; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE INHIBITOR; PROTEIN P21; SHORT CHAIN FATTY ACID; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP3; TRICHOSTATIN A; UNCLASSIFIED DRUG;

ACETYLATION; APOPTOSIS; BINDING SITE; CANCER PREVENTION; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHROMATIN STRUCTURE; CONFERENCE PAPER; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MAMMAL CELL; REPRESSOR GENE; STRUCTURE ACTIVITY RELATION;

MAMMALIA;

EID: 0038676409     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/133.7.2485s     Document Type: Conference Paper

References (89)

1. Hinnebusch, B. F., Meng, S., Wu, J. T., Archer, S. Y. & Hodln, R. A. (2002) The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation. J. Nutr. 132: 1012-1017.
2. Emenaker, N. J., Calaf, G. M., Cox, D., Basson, M. D. & Qureshi, N. (2001) Short-chain fatty acids inhibit invaslve human colon cancer by modulating uPA, TIMP-1, TIMP-2, mutant p53, Bcl-2, Bax, p21 and PCNA protein expression in an in vitro cell culture model. J. Nutr. 131 (suppl. 11): 3041S-3046S.
3. Sun, J.-M., Chen, H, Y. & Davie, J. R. (2001) Effect of estradiol on histone acetylation dynamics in human breast cancer cells. J. Biol. Chem. 276: 49435-49442.
4. Hendzel, M. J., Delcuve, G. P. & Davie, J. R. (1991) Histone deacetylase is a component of the internal nuclear matrix. J. Biol. Chem, 266: 21936-21942.
5. Covault, J. & Chalkley, R. (1980) The Identification of distinct populations of acetylated histone. J. Biol. Chem. 255: 9110-9116.
6. Zhang, D.-E. & Nelson, D. A. (1988) Histone acetylation in chicken erythrocytes: rates of acetylation and evidence that histones in both active and potentially active chromatin are rapidly modified. Biochem. J. 250: 233-240.
7. Sun, J. M., Chen, H. Y., Moniwa, M., Litchfield, D, W., Seto, E. & Davie, J. R. (2002) The transcriptional repressor Sp3 is associated with CK2 phosphorylated histone deacetylase 2. J. Biol. Chem. 277: 35783-35786.
8. Prasad, K. N. & Sinha, P. K. (1976) Effect of sodium butyrate on mammalian cells in culture: a review. In Vitro 12: 125-132.
9. Leder, A. & Leder, P. (1975) Butyric acid, a potent inducer of erythroid differentiation in cultured erythroleukemic cells. Cell 5: 319-322.
10. Riggs, M. G., Whittaker, R. G., Neumann, J. R. & Ingram, V. M. (1977) n-Butyrate causes histone modification in HeLa and Friend erythroleukaemia cells. Nature 268: 462-464.
11. Candido, E. P. M., Reeves, R. & Davie, J. R. (1978) Sodium butyrate inhibits histone deacetylation in cultured cells. Cell 14: 105-113.
12. Sealy, L. & Chalkley, R. (1978) The effect of sodium butyrate on histone modification. Cell 14: 115-121.
13. Boffa, L. C., Vidali, G., Mann, R. S. & Allfrey, V. G. (1978) Suppression of histone deacetylation in vivo and in vitro by sodium butyrate. J. Biol. Chem. 253: 3364-3366.
14. Vidali, G., Boffa, L. C., Bradbury, E. M. & Allfrey, V. G. (1978) Suppression of histone deacetylation by butyrate leads to accumulation of multiacetylated forms of histones H3 and H4 and increased DNase I-sensitivity of the associated DNA sequences. Proc. Natl. Acad. Sci. U.S.A. 75: 2239-2243.
15. Luger, K., Mader, A. W., Richmond, R. K., Sargent, D. F. & Richmond, T. J. (1997) Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 389: 251-260.
16. Luger, K. & Richmond, T. J. (1998) The histone tails of the nucleosome. Curr. Opin. Genet. Dev. 8: 140-146.
17. Spencer, V. A. & Davie, J. R. (1999) Role of covalent modifications of histones in regulating gene expression. Gene 240: 1-12.
18. Pogo, B. G., Allfrey, V. G. & Mirsky, A. E. (1966) RNA synthesis and histone acetylation during the course of gene activation in lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 55: 805-812.
19. Garcia-Ramirez, M., Rocchini, C. & Ausio, J. (1995) Modulation of chromatin folding by histone acetylation. J. Biol. Chem. 270: 17923-17928.
20. Wang, X., He, C., Moore, S. C. & Ausio, J. (2001) Effects of histone acetylation on the solubility and folding of the chromatin fiber. J. Biol. Chem. 276: 12764-12768.
21. Tse, C., Sera, T., Wolffe, A. P. & Hansen, J. C. (1998) Disruption of higher order folding by core histone acetylation dramatically enhances transcription of nucleosomal arrays by RNA polymerase III. Mol. Cell. Biol. 18: 4629-4638.
22. Hansen, J. C., Tse, C. & Wolffe, A. P. (1998) Structure and function of the core histone N-termini: more than meets the eye. Biochemistry 37: 17637-17641.
23. Wang, X., Moore, S. C., Laszczak, M. & Ausio, J. (2000) Acetylation increases the alpha-helical content of the histone tails of the nucleosome. J. Biol. Chem. 275: 35013-35020.
24. Nightingale, K. P., Wellinger, R. E., Sogo, J. M. & Becker, P. B. (1998) Histone acetylation facilitates RNA polymerase II transcription of the drosophila hsp26 gene in chromatin. EMBO J. 17: 2865-2876.
25. Davie, J. R, & Moniwa, M, (2000) Control of chromatin remodeling. Crit. Rev. Eukaryot. Gene Expr. 10: 303-325.
26. Sterner, D. E. & Berger, S. L. (2000) Acetylation of histones and transcription-related factors. Microbiol. Mol. Biol. Rev. 64: 435-459.
27. Fischle, W., Emiliani, S., Hendzel, M. J., Nagase, T., Nomura, N., Voelter, W. & Verdin, E. (1999) A new family of human histone deacetylases related to Saccharomyces cerevisiae HDA1p. J. Biol. Chem. 274: 11713-11720.
28. Grozinger, C. M., Hassig, C. A. & Schreiber, S. L. (1999) Three proteins define a class of human histone deacetylases related to yeast Hda1p. Proc. Natl. Acad. Sci. U.S.A. 96: 4868-4873.
29. Fischle, W., Kiermer, V., Dequiedt, F. & Verdin, E. (2001) The emerging role of class II histone deacetylases. Biochem. Cell Biol. 79: 337-348.
30. Grozinger, C. M. & Schreiber, S. L. (2002) Deacetylase enzymes: biological functions and the use of small-molecule inhibitors. Chem. Biol. 9: 3-16.
31. Guardiola, A. R. & Yao, T. P. (2002) Molecular cloning and characterization of a novel histone deacetylase HDAC10. J. Biol. Chem. 277: 3350-3356.
32. Kao, H. Y., Lee, C. H., Komarov, A., Han, C. C. & Evans, R. M. (2002) Isolation and characterization of mammalian HDAC10, a novel histone deacetylase. J. Biol. Chem. 277: 187-193.
33. Herrera, J. E., Sakaguchi, K., Bergel, M., Trieschmann, L., Nakatani, Y. & Bustin, M. (1999) Specific acetylation of chromosomal protein HMG-17 by PCAF alters its interaction with nucleosomes. Mol. Cell. Biol. 19: 3466-3473.
34. Munshi, N., Merika, M., Yie, J., Senger, K., Chen, G. & Thanos, D. (1998) Acetylation of HMG I(Y) by CBP turns off IFN beta expression by disrupting the enhanceosome. Mol. Cell 2: 457-467.
35. Sterner, R., Vidali, G. & Allfrey, V. G. (1979) Studies of acetylation and deacetylation in high mobility group proteins: identification of the sites of acetylation in HMG 1. J. Biol. Chem. 254: 11577-11583.
36. Braun, H., Koop, R., Ertmer, A., Nacht, S. & Suske, G. (2001) Transcription factor Sp3 is regulated by acetylation. Nucleic Acids Res. 29: 4994-5000.
37. Cheung, W. L., Briggs, S. D. & Allis, C. D. (2000) Acetylation and chromosomal functions. Curr. Opin. Cell Biol. 12: 326-333.
38. Berger, S. L. (1999) Gene activation by histone and factor acetyltransferases. Curr. Opin. Cell Biol. 11: 336-341.
39. Davie, J. R. (1997) Nuclear matrix, dynamic histone acetylation and transcriptionally active chromatin. Mol. Biol. Rep. 24: 197-207.
40. Wu, R. S., Panusz, H. T., Hatch, C. L. & Bonner, W. M. (1986) Histones and their modifications. CRC Crit. Rev. Biochem. 20: 201-263.
41. Spencer, V. A. & Davie, J. R. (2001) Dynamically acetylated histone association with transcriptionally active and competent genes in the avian adult β-globin gene domain. J. Biol. Chem. 276: 34810-34815.
42. Perry, M. & Chalkley, R. (1982) Histone acetylation increases the solubility of chromatin and occurs sequentially over most of the chromatin. A novel model for the biological role of histone acetylation. J. Biol. Chem. 257: 7336-7347.
43. Finnin, M. S., Donigian, J. R., Cohen, A., Richon, V. M., Rifkind, R. A., Marks, P. A., Breslow, R. & Pavletich, N. P. (1999) Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors. Nature 401: 188-193.
44. Cousens, L. S., Gallwitz, D. & Alberts, B. M. (1979) Different accessibilities in chromatin to histone acetylase. J. Biol. Chem. 254: 1716-1723.
45. Ayer, D. E. (1999) Histone deacetylases: transcriptional repression with SINers and NuRDs. Trends Cell Biol. 9: 193-198.
46. Knoepfler, P. S. & Eisenman, R. N. (1999) Sin meets NuRD and other tails of repression. Cell 99: 447-450.
47. Gray, S. G. & Teh, B. T. (2001) Histone acetylation/deacetylation and cancer: an "open" and "shut" case? Curr. Mol. Med. 1: 401-429.
48. Shang, Y., Hu, X., DiRenzo, J., Lazar, M. A. & Brown, M. (2000) Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103: 843-852.
49. Hart, L. L. & Davie, J. R. (2002) The estrogen receptor: more than the average transcription factor. Biochem. Cell Biol. 80: 335-341.
50. Ghosh, S. (1999) Regulation of inducible gene expression by the transcription factor NF-kappaB. Immunol. Res. 19: 183-189.
51. Zhong, H., May, M. J., Jimi, E. & Ghosh, S. (2002) The phosphorylation status of nuclear NF-kappaB determines its association with CBP/p300 or HDAC-1. Mol. Cell 9: 625-636.
52. Kruh, J. (1982) Effects of sodium butyrate, a new pharmacological agent, on cells in culture. Mol. Cell. Biochem. 42: 65-82.
53. Van Lint, C., Emiliani, S. & Verdin, E. (1996) The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation. Gene Expr. 5: 245-253.
54. Mariadason, J. M., Corner, G. A. & Augenlicht, L. H. (2000) Genetic reprogramming in pathways of colonic cell maturation induced by short chain fatty acids: comparison with trichostatin A, sulindac, and curcumin and implications for chemoprevention of colon cancer. Cancer Res. 60: 4561-4572.
55. Yang, J., Kawai, Y., Hanson, R. W. & Arinze, I. J. (2001) Sodium butyrate induces transcription from the G alpha(i2) gene promoter through multiple Sp1 sites in the promoter and by activating the MEK-ERK signal transduction pathway. J. Biol. Chem. 276: 25742-25752.
56. Siavoshian, S., Segain, J. P., Kornprobst, M., Bonnet, C., Cherbut, C., Galmiche, J. P. & Blottiere, H. M. (2000) Butyrate and trichostatin A effects on the proliferation/differentiation of human intestinal epithelial cells: induction of cyclin D3 and p21 expression. Gut 46: 507-514.
57. Tran, C. P., Familari, M., Parker, L. M., Whitehead, R. H. & Giraud, A. S. (1998) Short-chain fatty acids inhibit intestinal trefoil factor gene expression in colon cancer cells. Am. J. Physiol. Gastrointest. Liver Physiol. 275: G85-G94.
58. Lu, Y. & Lotan, R. (1999) Transcriptional regulation by butyrate of mouse galectin-1 gene in embryonal carcinoma cells. Biochim. Biophys. Acta 1444: 85-91.
59. Walker, G. E., Wilson, E. M., Powell, D. & Oh, Y. (2001) Butyrate, a histone deacetylase inhibitor, activates the human IGF binding protein-3 promoter in breast cancer cells: molecular mechanism involves an Sp1/Sp3 multiprotein complex. Endocrinology 142: 3817-3827.
60. Suske, G. (1999) The Sp-family of transcription factors. Gene 238: 291-300.
61. Mastrangelo, I. A., Courey, A. J., Wall, J. S., Jackson, S. P. & Hough, P. V. (1991) DNA looping and Sp1 multimer links: a mechanism for transcriptional synergism and enhancement. Proc. Natl. Acad. Sci. U.S.A. 88: 5670-5674.
62. Pascal, E. & Tjian, R. (1991) Different activation domains of Sp1 govern formation of multimers and mediate transcriptional synergism. Genes Dev. 5:1646-1656.
63. Ryu, S., Zhou, S., Ladurner, A. G. & Tjian, R. (1999) The transcriptional cofactor complex CRSP is required for activity of the enhancer-binding protein Sp1. Nature 397: 446-450.
64. Doetzlhofer, A., Rotheneder, H., Lagger, G., Koranda, M., Kurtev, V., Brosch, G., Wintersberger, E. & Seiser, C. (1999) Histone deacetylase 1 can repress transcription by binding to Sp1. Mol. Cell. Biol. 19: 5504-5511.
65. waf1/cip1 promoter activation induced by histone deacetylase inhibitor. J. Biol. Chem. 275: 1371-1376.
66. Porter, W., Saville, B., Hoivik, D. & Safe, S. (1997) Functional synergy between the transcription factor Sp1 and the estrogen receptor. Mol. Endocrinol. 11: 1569-1580.
67. Kennett, S. B., Udvadia, A. J. & Horowitz, J. M. (1997) Sp3 encodes multiple proteins that differ in their capacity to stimulate or repress transcription. Nucleic Acids Res. 25: 3110-3117.
68. Philipsen, S. & Suske, G. (1999) A tale of three fingers: the family of mammalian Sp/XKLF transcription factors. Nucleic Acids Res. 27: 2991-3000.
69. Tsai, S. C. & Seto, E. (2002) Regulation of histone deacetylase 2 by protein kinase CK2. J. Biol. Chem. 277: 31826-31833.
70. Niefind, K., Guerra, B., Ermakowa, I. & Issinger, O. G. (2001) Crystal structure of human protein kinase CK2: insights into basic properties of the CK2 holoenzyme. EMBO J. 20: 5320-5331.
71. Landesman-Bollag, E., Song, D. H., Romieu-Mourez, R., Sussman, D. J., Cardiff, R. D., Sonenshein, G. E. & Seldin, D. C. (2001) Protein kinase CK2: signaling and tumorigenesis in the mammary gland. Mol. Cell. Biochem. 227:153-165.
72. Landesman-Bollag, E., Romieu-Mourez, R., Song, D. H., Sonenshein, G. E., Cardiff, R. D. & Seldin, D. C. (2001) Protein kinase CK2 in mammary gland tumorigenesis. Oncogene 20: 3247-3257.
73. Tawfic, S., Yu, S., Wang, H., Faust, R., Davis, A. & Ahmed, K. (2001) Protein kinase CK2 signal in neoplasia. Histol. Histopathol. 16: 573-582.
74. Pflum, M. K., Tong, J. K., Lane, W. S. & Schreiber, S. L. (2001) Histone deacetylase 1 phosphorylation promotes enzymatic activity and complex formation. J. Biol. Chem. 276: 47733-47741.
75. Sowa, Y., Orita, T., Minamikawa-Hiranabe, S., Mizuno, T., Nomura, H. & Sakai, T. (1999) Sp3, but not Sp1, mediates the transcriptional activation of the p21/WAF1/Cip1 gene promoter by histone deacetylase inhibitor. Cancer Res. 59: 4266-4270.
76. Bai, L. & Merchant, J. L. (2000) Transcription factor ZBP-89 cooperates with histone acetyltransferase p300 during butyrate activation of p21waf1 transcription in human cells. J. Biol. Chem. 275: 30725-30733.
77. Richon, V. M., Sandhoff, T. W., Rifkind, R. A. & Marks, P. A. (2000) Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation. Proc. Natl. Acad. Sci. U.S.A. 97: 10014-10019.
78. cip1 expression by growth factors and the extracellular matrix reveals a role for transient ERK activity in G1 phase. J. Cell Biol. 146: 1255-1264.
79. Kip1 CDK "inhibitors" are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J. 18: 1571-1583.
80. Assoian, R. K. (1997) Anchorage-dependent cell cycle progression. J. Cell Biol. 136: 1-4.
81. Roovers, K. & Assoian, R. K. (2000) Integrating the MAP kinase signal into the G1 phase cell cycle machinery. Bioessays 22: 818-826.
82. Nakano, K., Mizuno, T., Sowa, Y., Orita, T., Yoshino, T., Okuyama, Y., Fujita, T., Ohtani-Fujita, N., Matsukawa, Y., Tokino, T., Yamagishi, H., Oka, T., Nomura, H. & Sakai, T. (1997) Butyrate activates the WAF1/Cip1 gene promoter through Sp1 sites in a p53-negative human colon cancer cell line. J. Biol. Chem. 272: 22199-22206.
83. Butler, L. M., Webb, Y., Agus, D. B., Higgins, B., Tolentino, T. R., Kutko, M. C., LaQuaglia, M. P., Drobnjak, M., Cordon-Cardo, C., Scher, H. I., Breslow, R., Richon, V. M., Rifkind, R. A. & Marks, P. A. (2001) Inhibition of transformed cell growth and induction of cellular differentiation by pyroxamide, an inhibitor of histone deacetylase. Clin. Cancer Res. 7: 962-970.
84. Marks, P. A., Rifkind, R. A., Richon, V. M. & Breslow, R. (2001) Inhibitors of histone deacetylase are potentially effective anticancer agents. Clin. Cancer Res. 7: 759-760.
85. Richon, V. M., Zhou, X., Rifkind, R. A. & Marks, P. A. (2001) Histone deacetylase inhibitors: development of suberoylanitide hydroxamic acid (SAHA) for the treatment of cancers. Blood Cells Mol. Dis. 27: 260-264.
86. Marks, P. A., Richon, V. M. & Rifkind, R. A. (2000) Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells. J. Natl. Cancer Inst. 92: 1210-1216.
87. Warrell, R. P., JR., He, L. Z., Richon, V., Calleja, E. & Pandolfi, P. P. (1998) Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase. J. Natl. Cancer Inst. 90: 1621-1625.
88. He, L. Z., Tolentino, T., Grayson, P., Zhong, S., Warrell, R. P., JR., Rifkind, R. A., Marks, P. A., Richon, V. M. & Pandolfi, P. P. (2001) Histone deacetylase inhibitors induce remission in transgenic models of therapy-resistant acute promyelocytic leukemia. J. Clin. Invest. 108: 1321-1330.
89. Sowa, Y. & Sakai, T. (2000) Butyrate as a model for "gene-regulating chemoprevention and chemotherapy." Biofactors 12: 283-287.